Mount Sinai researchers have broken new ground in the understanding of the MDM2 gene -- which is often overexpressed in cancer -- finding that when it acts with a specific protein, it can lead to cancer cell death. The study appears in the May 2, 2019, print edition of Molecular Cell.
